Patents by Inventor Vincent Descamps

Vincent Descamps has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treatment of human papillomaviruses related chronic infections
    Patent number: 11401326
    Abstract: Embodiments of the disclosure relate to the use of an IL-17 pathway inhibitor for treating chronic infections caused by one or more HPVs.
    Type: Grant
    Filed: May 24, 2017
    Date of Patent: August 2, 2022
    Assignees: Assistance Publique—Hopitaus De Paris, Universite Paris Diderot—Paris 7
    Inventors: Vincent Descamps, Florence Brunet-Possenti
  • INTERLEUKIN-17 PATHWAY INHIBITOR FOR THE TREATMENT OF CHRONIC HPV INFECTIONS
    Publication number: 20200308269
    Abstract: Embodiments of the disclosure relate to the use of an IL-17 pathway inhibitor for treating chronic infections caused by one or more HPVs.
    Type: Application
    Filed: May 24, 2017
    Publication date: October 1, 2020
    Applicants: ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS, UNIVERSITE PARIS DIDEROT - PARIS 7
    Inventors: Vincent Descamps, Florence Brunet-Possenti
  • Composition for the in vivo production of therapeutic products
    Patent number: 6464998
    Abstract: The present invention provides cell compositions for in vivo implantation, and designed for the sustained and controlled delivery of therapeutic substances.
    Type: Grant
    Filed: July 11, 1996
    Date of Patent: October 15, 2002
    Assignee: Aventis Pharma S.A.
    Inventors: Yves Beuzard, Olivier Danos, Vincent Descamps, Jean-Michel Heard, Philippe Moullier, Nadia Naffakh, Michel Perricaudet, William Vainchenker
  • Method for preparing recombinant adeno-associated viruses (AAV), and uses thereof
    Patent number: 5789390
    Abstract: A novel method for preparing vectors derived from adeno-associated viruses (AAV), cells used therefor, and the use of the resulting vectors, particularly in gene and/or cell therapy, are disclosed.
    Type: Grant
    Filed: July 25, 1996
    Date of Patent: August 4, 1998
    Assignee: Rhone-Poulenc Rorer S.A.
    Inventors: Vincent Descamps, Michel Perricaudet